Scarica l'app Stockscreener
1.77
4.32%
-0.08
Dopo l'orario di chiusura:
1.80
0.03
+1.69%
Engene Therapeutics Inc Azioni (ENGN) Dati Finanziari
Conto economico
Trimestrale
*Tutti i numeri sono espressi in milioni
| Data di fine periodo | 2026-01-31 | 2025-10-31 | 2025-07-31 | 2025-04-30 | 2024-07-31 |
| Durata del periodo | 3 mesi | 3 mesi | 3 mesi | 3 mesi | 3 mesi |
| Revenues |
-
|
- | - | - | - |
Operating Expenses
|
21.01%
31.18
|
39.48 | 29.95 | 27.12 | 16.76 |
| Operating Income/Loss |
21.01%
-31.18
|
-39.48 | -29.95 | -27.12 | -16.76 |
| Nonoperating Income/Loss |
29.80%
1.433
|
1.104 | 1.195 | 1.549 | 2.582 |
| Income/Loss From Continuing Operations Before Tax |
22.47%
-29.75
|
-38.38 | -28.75 | -25.57 | -14.18 |
| Income Tax Expense/Benefit |
100.00%
-
|
-0.497 | 0.239 | 0.24 | -0.029 |
| Income/Loss From Continuing Operations After Tax |
21.46%
-29.75
|
-37.88 | -28.99 | -25.82 | -14.15 |
|
Net Income/Loss
|
21.46%
-29.75
|
-37.88 | -28.99 | -25.82 | -14.15 |
| Preferred Stock Dividends And Other Adjustments |
-
|
- | - | - | - |
| Attributable To Noncontrolling Interest |
-
|
- | - | - | - |
| Basic Average Shares |
76,456%
67.26
|
0.0879 | 51.10 | 51.02 | 44.17 |
| Diluted Average Shares |
76,456%
67.26
|
0.0879 | 51.10 | 51.02 | 44.17 |
| Basic Earnings Per Share |
39.73%
0.44
|
0.73 | 0.57 | 0.51 | 0.32 |
| Diluted Earnings Per Share |
39.73%
0.44
|
0.73 | 0.57 | 0.51 | 0.32 |
| Common Stock Dividends |
-
|
- | - | - | - |
| Participating Securities, Distributed And Undistributed Earnings/Loss, Basic |
-
|
- | - | - | - |
3.04%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):